Acute chest pain remains one of the most common and challenging symptoms encountered in clinical practice. It is crucial to promptly and accurately diagnose the underlying cause, as the range of potential etiologies includes life-threatening conditions.
The initial approach should involve a thorough history and physical examination. Key historical elements include the nature, location, and duration of the pain, associated symptoms, and risk factors for coronary artery disease. The physical examination should aim to identify signs of cardiopulmonary disease or other potential causes of chest pain.
Electrocardiography (ECG) is the first-line diagnostic test for patients presenting with acute chest pain. Subsequent testing should be guided by the clinical suspicion for specific conditions. High-risk patients may warrant immediate invasive strategies, while low-risk patients may undergo further non-invasive testing.
Imaging modalities such as echocardiography, computed tomography (CT), and magnetic resonance imaging (MRI) can provide additional diagnostic information. For instance, CT coronary angiography can be useful in ruling out coronary artery disease in low to intermediate risk patients.
The management of acute chest pain should be tailored to the underlying cause. In cases of acute coronary syndrome, immediate reperfusion therapy is indicated. Other conditions may require medical management, surgical intervention, or observation depending on the specific diagnosis.
Acute chest pain is a complex clinical challenge requiring a comprehensive and systematic approach. A thorough history and physical examination, coupled with judicious use of diagnostic testing, can facilitate accurate diagnosis and appropriate management. Continued research and advancements in diagnostic modalities promise to further enhance our ability to evaluate and manage this common clinical conundrum.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation